Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Modified-CVAD Or Modified-Cbad Compared To High Dose Cyclophosphamide For Peripheral Blood Stem Cell Mobilization In Patients With Multiple Myeloma

Suzanne C Gettys, PharmD, Alison M Gulbis, PharmD, BCOP, Kaci Wilhelm, PharmD, BCOP, Yvonne T Dinh, Gabriela Rondon, MD, Muzaffar H. Qazilbash, MD

Blood (2013) 122 (21): 2036.

https://doi.org/10.1182/blood.V122.21.2036.2036

Published: 2013

Journal Articles

Autologous Stem Cell Transplantation in Waldenstrom's Macroglobulinemia

Krina Patel, MD, Rima M Saliba, PhD, Nina Shah, MD, Qaiser Bashir, Sheeba K. Thomas, MD, Yvonne T Dinh, Chitra M. Hosing, M.D., Uday R. Popat, M.D., Simrit Parmar, M.D., Sergio A Giralt, MD, Richard E. Champlin, Muzaffar H. Qazilbash, MD

Blood (2012) 120 (21): 4533.

https://doi.org/10.1182/blood.V120.21.4533.4533

Published: 2012

Journal Articles

EBMT Risk Score for Pre Transplant Risk Assessment in Patients with Multiple Myeloma.

Zartash Gul, MD, Hasan Khan, Qaiser Bashir, MD, Nina Shah, MD, Simrit Parmar, M.D., Yvonne T Dinh, Chitra M. Hosing, M.D., Uday R. Popat, M.D., Partow Kebriaei, M.D., Paolo Anderlini, MD, Elizabeth J Shpall, MD, Sergio Giralt, MD, Richard E. Champlin, Muzaffar H. Qazilbash, MD

Blood (2012) 120 (21): 3094.

https://doi.org/10.1182/blood.V120.21.3094.3094

Published: 2012

Journal Articles

Cardiac Toxicity After High-Dose Melphlan and Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Zartash Gul, MD, Qaiser Bashir, MD, Yago Nieto, M.D., Ph.D., Nazeer Sherwani, Simrit Parmar, M.D., Nina Shah, MD, Yvonne T Dinh, Chitra M. Hosing, M.D., Uday R. Popat, M.D., Partow Kebriaei, M.D., Elizabeth J Shpall, MD, Sergio A Giralt, MD, Richard E. Champlin, Muzaffar H. Qazilbash, MD

Blood (2012) 120 (21): 2027.

https://doi.org/10.1182/blood.V120.21.2027.2027

Published: 2012

Journal Articles

Role of Serum Lactate Dehydrogenase (LDH) As a Prognostic Marker for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.

Krina Patel, MD, Robert Z. Orlowski, M.D., Ph.D., Nina Shah, MD, Qaiser Bashir, Simrit Parmar, M.D., Yvonne T Dinh, Gabriela Rondon, MD, Sergio A Giralt, MD, Richard E. Champlin, Muzaffar Qazilbash, M.D.

Blood (2012) 120 (21): 3115.

https://doi.org/10.1182/blood.V120.21.3115.3115

Published: 2012

Journal Articles

A Comparative Study of the Outcome of High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with High-Risk or Standard-Risk Myeloma Treated Concurrently,

Syed Kazmi, MD, Gary Lu, MD, Nina Shah, MD, Qaiser Bashir, MD, Simrit Parmar, M.D., Robert Z. Orlowski, MD, PhD, Jatin J Shah, MD, Chitra M Hosing, MD, Uday Popat, M.D., Yvonne T Dinh, Sofia Qureshi, Gabriela Rondon, MD, Sergio Giralt, MD, Richard Champlin, MD, Muzaffar H. Qazilbash, MD

Blood (2011) 118 (21): 4156.

https://doi.org/10.1182/blood.V118.21.4156.4156

Published: 2011

Journal Articles

Impact of Non High-Risk Chromosomal Abnormalities on the Outcome of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Sairah Ahmed, MD, Heather Lin, PhD, Veera Baladandayuthapani, PhD, Mubeen A Khan, Gary Lu, MD, Gabriela Rondon, MD, Sofia Qureshi, Yvonne T Dinh, Qaiser Bashir, MD, Nina Shah, MD, Simrit Parmar, M.D., Chitra M Hosing, MD, Uday Popat, M.D., Sergio A Giralt, MD, Robert Z. Orlowski, MD, PhD, Jatin J Shah, MD, Richard Champlin, MD, Muzaffar H. Qazilbash, MD

Blood (2011) 118 (21): 333.

https://doi.org/10.1182/blood.V118.21.333.333

Published: 2011

Journal Articles

Survival Disparities Between African-American and Caucasian Patients Treated with Autologous Stem Cell Transplantation for Multiple Myeloma Are Eliminated in the Era of Novel Therapeutics

Sairah Ahmed, MD, Yvonne T Dinh, Sofia Qureshi, Gabriela Rondon, MD, Qaiser Bashir, MD, Simrit Parmar, M.D., Tiffany Avery, MD, MPH, Robert Z. Orlowski, MD, PhD, Richard Champlin, MD, Muzaffar Qazilbash, MD, Nina Shah, MD

Blood (2011) 118 (21): 2017.

https://doi.org/10.1182/blood.V118.21.2017.2017

Published: 2011

Journal Articles

Response Before Autologous Hematopoietic Stem Cell Transplantation Is An Important Predictor of Outcome in Multiple Myeloma,

Shatha Farhan, MD, Heather Lin, PhD, Veerabhadran Baladandayuthapani, Nina Shah, MD, Qaiser Bashir, MD, Chitra M Hosing, MD, Uday Popat, M.D., Simrit Parmar, M.D., Yvonne T Dinh, Sofia Qureshi, Gabriela Rondon, MD, Sergio Giralt, MD, Richard Champlin, MD, Muzaffar H. Qazilbash, MD

Blood (2011) 118 (21): 4119.

https://doi.org/10.1182/blood.V118.21.4119.4119

Published: 2011

Journal Articles

Increased Bone Marrow Plasma Cell Infiltration Pre-Transplant Is Associated with Worse Outcomes in Patients Undergoing High Dose Chemotherapy and Autologous Stem Cell Transplantation for Multiple Myeloma,

Nina Shah, MD, Qaiser Bashir, MD, Simrit Parmar, M.D., Yvonne T Dinh, Sofia Qureshi, Gabriela Rondon, MD, Uday R Popat, MD, Yago Nieto, MD, PhD, Roy Jones, MD, PhD, Richard Champlin, MD, Muzaffar H. Qazilbash, MD

Blood (2011) 118 (21): 4135.

https://doi.org/10.1182/blood.V118.21.4135.4135

Published: 2011

Journal Articles

A Randomized Phase II Trial of Fludarabine/Melphalan 140 Vs Fludarabine/ Melphalan 100 Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Multiple Myeloma,

Muzaffar Qazilbash, MD, Peter F Thall, PhD, Ping Liu, Robert Z. Orlowski, MD, PhD, Qaiser Bashir, MD, Nina Shah, MD, Partow Kebriaei, MD, Simrit Parmar, MD, Roy Jones, MD, PhD, Chitra M Hosing, MD, Uday R Popat, MD, Yvonne T Dinh, Gabriela Rondon, MD, Jatin J Shah, MD, Marcos De Lima, MD, Richard Champlin, MD, Sergio Giralt, MD

Blood (2011) 118 (21): 4108.

https://doi.org/10.1182/blood.V118.21.4108.4108

Published: 2011

Journal Articles

Durable Responses with Autologous Hematopoietic Stem Cell Transplantation in Patients with POEMS Syndrome

Krina Patel, MD, Robert Z. Orlowski, MD, PhD, Nina Shah, MD, Qaiser Bashir, MD, Yvonne T Dinh, Gabriela Rondon, MD, Sergio Giralt, MD, Richard Champlin, MD, Muzaffar H Qazilbash, MD

Blood (2011) 118 (21): 4522.

https://doi.org/10.1182/blood.V118.21.4522.4522

Published: 2011

NARROW

Modified-CVAD Or Modified-Cbad Compared To High Dose Cyclophosphamide For Peripheral Blood Stem Cell Mobilization In Patients With Multiple Myeloma

Autologous Stem Cell Transplantation in Waldenstrom's Macroglobulinemia

EBMT Risk Score for Pre Transplant Risk Assessment in Patients with Multiple Myeloma.

Cardiac Toxicity After High-Dose Melphlan and Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Role of Serum Lactate Dehydrogenase (LDH) As a Prognostic Marker for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.

A Comparative Study of the Outcome of High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with High-Risk or Standard-Risk Myeloma Treated Concurrently,

Impact of Non High-Risk Chromosomal Abnormalities on the Outcome of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Survival Disparities Between African-American and Caucasian Patients Treated with Autologous Stem Cell Transplantation for Multiple Myeloma Are Eliminated in the Era of Novel Therapeutics

Response Before Autologous Hematopoietic Stem Cell Transplantation Is An Important Predictor of Outcome in Multiple Myeloma,

Increased Bone Marrow Plasma Cell Infiltration Pre-Transplant Is Associated with Worse Outcomes in Patients Undergoing High Dose Chemotherapy and Autologous Stem Cell Transplantation for Multiple Myeloma,

A Randomized Phase II Trial of Fludarabine/Melphalan 140 Vs Fludarabine/ Melphalan 100 Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Multiple Myeloma,

Durable Responses with Autologous Hematopoietic Stem Cell Transplantation in Patients with POEMS Syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only